九洲藥業(603456.SH)股東羅月芳解除質押650萬股
格隆匯10月22日丨九洲藥業(603456.SH)公佈,2018年7月11日,公司持股5%以上股東羅月芳將其持有的3,600萬股九洲藥業無限售流通股(佔公司總股本的4.47%)在浙商證券辦理了股票質押式回購交易,約定購回交易日期為2019年7月12日。
在本次約定贖回交易日屆滿前,羅月芳與浙商證券辦理了前述3600萬股九洲藥業股票的質押延期購回業務,約定購回交易日期為2020年7月12日。
2019年10月21日,羅月芳將質押給浙商證券的650萬股(佔公司總股本的0.81%)九洲藥業無限售流通股提前辦理了解除質押手續。
截止本公告日,羅月芳共持有公司無限售條件流通股4514.4萬股(佔九洲藥業總股本的5.60%),已累計質押股份2950萬股(佔其持有公司股份數量的65.35%),佔九洲藥業總股本的3.66%。
截止本公告日,羅月芳及其一致行動人合計持有公司無限售條件流通股4.71億股(佔九洲藥業總股本的58.47%),已累計質押股份2.45億股(佔其持有公司股份數量的51.94%),佔九洲藥業總股本的30.37%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.